Filing Details

Accession Number:
0001140361-12-026163
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-05-17 13:00:00
Reporting Period:
2012-05-15
Filing Date:
2012-05-17
Accepted Time:
2012-05-17 18:20:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1247681 Bryan V Lawlis C/O Biomarin Pharmaceutical Inc.
105 Digital Drive
Novato CA 94949
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-05-15 6,400 $14.39 19,800 No 4 M Direct
Common Stock Disposition 2012-05-15 8,900 $38.51 13,400 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2012-05-15 6,400 $14.39 6,400 $14.39
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
92,100 2009-11-12 2019-05-11 No 4 M Direct
Footnotes
  1. The price in Column 4 is a weighted average price. The prices actually received ranged from $38.50 to $38.56. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  2. Original option vests 6/48ths on November 12, 2009 and 1/48th on the 12th of every month thereafter.